5メトキシトリプタミンの構造的薬理と治療的可能性
Audrey L Warren1, David Lankri2, Michael J Cunningham2
1Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nature
|May 8, 2024
まとめ
研究者は,5-メトキシ-N,N-ジメチルトリプタミン (5-MeO-DMT) がセロトニン受容体とどのように相互作用するかを明らかにしました. 選択的な5-MeO-DMT化合物は,幻覚を引き起こす性質のない抗不安薬と抗うつ薬の効果を示し,新しい神経精神薬の開発を支援した.
科学分野:
- 神経科学
- 精神薬学
- 構造生物学
背景:
- LSDやサイロシビンのようなサイケデリックは 主にセロトニン5HT2A受容体を通して 神経精神疾患の治療に有望です
- セロトニン5HT1A受容体は,5-メトキシ-N,N-ジメチルトリプトミン (5-MeO-DMT) を含むトリプトミン幻覚剤の作用に関与しているが,その正確な役割は不明である.
- 5-HT1Aは治療目標であるが,サイケデリックがこの受容体と媒介効果を誘発するメカニズムはほとんど不明である.
研究 の 目的:
- セロトニン5-HT1A受容体との5メトキシ-N,N-ジメチルトリプタミン (5-MeO-DMT) 相互作用の分子メカニズムを解明する.
- 5-メトキシトリプタミンの 5-HT1Aおよび5-HT2A受容体の構造-活性関係を特徴づける.
- 神経精神疾患に対するセレクティブ5HT1Aアゴニストの治療の可能性を調査する.
主な方法:
- 低温電子顕微鏡 (cryo-EM) で,5-HT1Aが5-MeO-DMTに結合する5つの構造を決定する.
- 体系的な薬剤化学と受容体変異により,構造-活性関係を分析する.
- ネズミの受容体活性と機能的効果を評価するためのインビトロ薬理学アッセイと行動研究.
主要な成果:
- 詳細な分子構造は,5-MeO-DMTとその類似体が5-HT1A受容体とどのように相互作用するかを明らかにする.
- 5HT1Aの信号伝達力,有効性および選択性の主要な決定因子を特定した.
- 5-HT1A選択的5-MeO-DMTアナログは,幻覚誘発のような行動を引き起こすことなく,マウスで抗うつ剤のような効果を示した.
結論:
- この研究は前例のない サイケデリックと5-HT1A受容体の 相互作用に関する 分子洞察を提供します
- 5- MeO- DMT アナログによる5- HT1A受容体の選択的調節は,神経精神疾患の潜在的な治療戦略を提供します.
- これらの発見は不安やうつ病などの 5-HT1A経路を標的とした 新種の治療法の合理的な設計への道を開きます
関連する概念動画
CNS Stimulants: Psychedelic Agents
147
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
147
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
187
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
187
Antipsychotic Drugs: Typical and Atypical Agents
186
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
186


